1. Academic experts
  2. Research students
  3. Students
  4. Alumni
  5. Senior people at City
  6. Non-academic staff
  7. Honorary graduates

Marie-Rose Dwek

Research Assistant & PhD Student

School of Health Sciences

Visit Marie-Rose Dwek

Myddelton Street Building

Postal address

City, University of London
Northampton Square
United Kingdom



Since finishing an MSc in Health Psychology run jointly between University College London and King’s College London in 2010, Marie-Rose has been involved in a number of research projects at various institutions including Queen Mary University and the Department of Health’s Whole System’s Demonstrator (WSD) project.

Marie-Rose is a PhD student at City, University of London and a research assistant. She set up her PhD study in 2013, obtaining NHS ethical approval to examine the relationship between adjuvant chemotherapy treatment and cognitive impairment in colorectal cancer patients across a number of London based NHS Trusts, using both quantitative and qualitative research methods. Her PhD supervisors are Professor S Newman and Dr L Rixon.

Marie-Rose is a student member of the British Psychological Society (BPS).


  1. Postgraduate Certificate in Academic Practice (Distinction), City, University of London, London, United Kingdom, Oct 2016
  2. Masters in Health Psychology (Merti), University College London, United Kingdom, Sep 2009 – Sep 2010
  3. BSc (Hons) Psychology (2:1), Birkbeck, University of London, London, United Kingdom


  1. Research Assistant and PhD Student, City, University of London, Oct 2013 – present


French (can read, speak and understand spoken).


Geographic Areas

  • Europe


Title of thesis: Cancer, Chemotherapy, Cognition and Quality of Life

Oct 2013 – Oct 2018

Summary of research

The overall aim of this thesis is to design and conduct a mixed method study which will determine whether chemotherapy is related to adverse cognitive effects in colorectal cancer patients. The thesis aims to examine the nature and duration of any such cognitive impairment and whether the cognitive deterioration, if present, contributes to decline in HRQoL. The quantitative part of the study, takes into account the International Cognition and Cancer Task Force (ICCTF) (founded in 2006) recommendations (Wefel et al, 2011).


Journal articles (4)

  1. Dwek, M.R., Rixon, L., Hurt, C., Simon, A. and Newman, S. (2017). Is there a relationship between objectively measured cognitive changes in patients with solid tumours undergoing chemotherapy treatment and their health-related quality of life outcomes? A systematic review. Psycho-Oncology, 26(10), pp. 1422–1432. doi:10.1002/pon.4331.
  2. dwek, M., Rixon, L., Simon, A., Hurt, C. and Newman, S. (2016). Examining Chemotherapy-Related Cognitive Changes in Colorectal Cancer Patients: A Feasibility Trial. Cancer Open Access, 1(1), pp. 5–8.
  3. Dwek, M.R., Mcbain, H., Cleanthous, S., Shipley, M. and Newman, S. (2015). Osteoarthritis: Patient Expectations about Future Pain, Stiffness and Function. Musculoskeletal Care, 13(2), pp. 84–92. doi:10.1002/msc.1089.
  4. Dwek, M.R., Rixon, L., Simon, A., Hurt, C. and Newman, S. (2015). Examining the effects of adjuvant chemotherapy on cognition and the impact of any cognitive impairment on quality of life in colorectal cancer patients: Study protocol. BMC Psychology, 3(1). doi:10.1186/S40359-015-0100-5.